A Trial of Contraceptive Methods in Women with Systemic Lupus Erythematosus
Authors:
- Jorge Sánchez-GuerreroJSJorge Sánchez-Guerrero
- América G. UribeAUAmérica G. Uribe
- Luisa Jiménez-SantanaLJLuisa Jiménez-Santana
- Marilú Mestanza-PeraltaMMMarilú Mestanza-Peralta
- Pilar Lara-ReyesPLPilar Lara-Reyes
- Armando H. SeucASArmando H. Seuc
- María-Del-Carmen CraviotoMCMaría-Del-Carmen Cravioto
Open Access
- 15 December 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (24) , 2539-2549
Abstract
The effects of estrogen-containing contraceptives on disease activity in women with systemic lupus erythematosus have not been determined.Keywords
This publication has 32 references indexed in Scilit:
- The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosusArthritis & Rheumatism, 1996
- Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control studyThe Lancet, 1995
- Can Women with Systemic Lupus Erythematosus Safely Use Exogenous Estrogens?JCR: Journal of Clinical Rheumatology, 1995
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992
- OESTROGEN-INDUCED SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1986
- Age- and sex-related glomerulonephritis in New Zealand white miceClinical Immunology and Immunopathology, 1980
- PROGESTERONE AND MAINTENANCE OF PREGNANCY: IS PROGESTERONE NATURE'S IMMUNOSUPPRESSANT?*Annals of the New York Academy of Sciences, 1977
- RHEUMATIC DISEASE, ABNORMAL SEROLOGY, AND ORAL CONTRACEPTIVESThe Lancet, 1972
- Rheumatic complaints of women using anti-ovulatory drugsJournal of Chronic Diseases, 1968
- L.E. CELLS AFTER ORAL CONTRACEPTIVESThe Lancet, 1968